These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11175387)

  • 1. Further characterization of the discriminative stimulus effects of buspirone using monoamine agonists and antagonists in the pigeon.
    Nader MA; Hoffmann S; Gleeson S; Barrett JE
    Behav Pharmacol; 1989; 1(1):57-67. PubMed ID: 11175387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the discriminative stimulus effects of 8-OH-DPAT, buspirone and the beta-adrenoreceptor antagonist pindolol after chronic administration of the 5-HT(1A) agonist 8-OH-DPAT in the pigeon.
    Zhang L; Barrett JE
    Behav Pharmacol; 1991 Nov; 2(4 And 5):369-378. PubMed ID: 11224080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent discriminative stimulus properties of 8-OH-DPAT.
    Ybema CE; Slangen JL; Olivier B; Mos J
    Behav Pharmacol; 1993 Dec; 4(6):610-624. PubMed ID: 11224230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus characteristics of BMY 14802 in the pigeon.
    Vanecek SA; Essman WD; Taylor DP; Woods JH
    J Pharmacol Exp Ther; 1998 Jan; 284(1):1-9. PubMed ID: 9435153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the discriminative stimulus effects of d-amphetamine in rhesus monkeys with serotonin 5-HT(1A) agonists.
    Nader MA; Woolverton WL
    Behav Pharmacol; 1994 Oct; 5(6):591-598. PubMed ID: 11224238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats.
    Powell KR; Picker MJ; Dykstra LA
    Behav Pharmacol; 1994 Jun; 5(3):255-264. PubMed ID: 11224275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
    Barrett JE; Hoffmann SM; Olmstead SN; Foust MJ; Harrod C; Weissman BA
    Psychopharmacology (Berl); 1989; 97(3):319-25. PubMed ID: 2524083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190.
    Barrett JE; Gleeson S
    Eur J Pharmacol; 1992 Jul; 217(2-3):163-71. PubMed ID: 1425937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline-serotonin interactions in the anxiolytic effects of 5-HT(1A) agonists.
    López-Rubalcava C; Fernández-Guasti A
    Behav Pharmacol; 1994 Feb; 5(1):42-51. PubMed ID: 11224250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of the novel anxiolytic buspirone.
    Ator NA
    Behav Pharmacol; 1991 Feb; 2(1):3-14. PubMed ID: 11224042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of buspirone in the pigeon.
    Mansbach RS; Barrett JE
    J Pharmacol Exp Ther; 1987 Feb; 240(2):364-9. PubMed ID: 3806400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of indorenate in a conditioned taste aversion paradigm.
    Miranda F; Hong E; Velázquez-Martínez DN
    Pharmacol Biochem Behav; 2001 Mar; 68(3):427-33. PubMed ID: 11325395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists.
    Callahan PM; Cunningham KA
    Neuropharmacology; 1997 Mar; 36(3):373-81. PubMed ID: 9175616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of the serotonergic compound eltoprazine.
    Ybema CE; Slangen JL; Olivier B; Mos J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
    Shin E; Garcia J; Winkler C; Björklund A; Carta M
    Neurobiol Dis; 2012 Sep; 47(3):393-406. PubMed ID: 22579773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of buspirone or gepirone with nicotine on schedule-controlled behavior of pigeons.
    Nader MA; Hannemann M
    Behav Pharmacol; 1993 Jun; 4(3):263-268. PubMed ID: 11224194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 5-HT(1A) receptor ligands on Fos-like immunoreactivity in rat brain: evidence for activation of noradrenergic transmission.
    Hajós-Korcsok E; Sharp T
    Synapse; 1999 Nov; 34(2):145-53. PubMed ID: 10502313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.